XOMAP
BEARISH
$25.92
Live
XOMA Royalty Corporation · NASDAQ
$25.21
52W Range
$30.0
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
85%
XOMAP exhibits a critical disconnect between its current market price ($25.92) and its deterministic value markers, with a Piotroski F-Score of 3/9 indicating weak financial health. The stock trades at a significant premium to both its Graham Number ($12.62) and Intrinsic Value ($7.01), suggesting severe overvaluation. While the company boasts exceptional profit margins (60.81%) and strong liquidity (Current Ratio 3.37), the bearish technical trend and poor insider sentiment outweigh these operational strengths. The high dividend yield of 8.32% appears risky given the underlying financial health score.
Key Strengths
Exceptional profit margins (60.81%) and gross margins (96.72%)
Strong Return on Equity (ROE) of 34.12%
Robust short-term liquidity with a Current Ratio of 3.37
Significant year-over-year revenue growth of 57.90%
Attractive dividend yield of 8.32%
Key Risks
Severe overvaluation relative to Graham Number and Intrinsic Value
Weak financial health as indicated by a Piotroski F-Score of 3/9
High volatility in revenue, evidenced by a -38.86% Q/Q decline
Bearish technical trend (0/100) and weak insider sentiment (40/100)
Debt-to-Equity ratio of 1.27 indicates moderate leverage
AI Fair Value Estimate
Based on comprehensive analysis
$12.62
-51.3% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare XOMAP against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning XOMAP from our newsroom.
Newest → oldest
No matching news yet.